⚡️NOW IN PRESS: Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy🧬 #PrecisionOncology 👉GU ASCO #GU24: Original multi-institutional series on off-label use of lurbi in SCBC-enriched GU cohorts Omar Alhalabi, MD

Amazing time at the lake house celebrating the arrival of our new first year fellows and beginning of the new academic year!

DOR to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation Enrique Grande Mohammad Jad Moussa, MD, MSc Nate Wilson Vivek Subbiah, MD Matt Campbell MD, MS Pavlos Msaouel Omar Alhalabi, MD oncodaily.com/blog/107634.ht… #Cancer #BladderCancer #CancerResearch #OncoDaily #Oncology

Very grateful for my experience attending the AACR-ASCO Methods in Clinical Cancer Research Workshop in La Jolla. Humbling to be surrounded by such incredible people, ideas, current and future leaders in this field

Important work led by rising ⭐️ Felipe Soto and mentors mehmetaltanmd Ajay Sheshadri to better understand outcomes for patients with NSCLC who have developed ICI-related pneumonitis sciencedirect.com/science/articl…

The Cancer-Immunity Cycle By Ira Mellman & colleagues in Immunity 2013: cell.com/immunity/fullt… 2023 update: cell.com/immunity/fullt… (L) 2013 (R) 2023 The underlying concepts have been the capstone for a lot of modern day cancer immunotherapy research.

Great #MultiDisciplinary work led by #MDAPulmonary Felipe Soto Ajay Sheshadri Lydia Glick BCM IM Residency Nate Wilson UTHealth Houston IM Residency Nicolas Palaskas, MD mehmetaltanmd on #LungCancer #ICIs #ILAs MD Anderson Cancer Center clinical-lung-cancer.com/article/S1525-…

Dermatology: important diagnosis

👋This is Mohammad Jad, Postdoc. Fellow & Postdoc. Association Team Leader MD Anderson Cancer Center, mentored by Matt Campbell MD, MS & Omar Alhalabi, MD 👉Applying for #InternalMedicine Residency #Match2025 🙏Dreaming of becoming a humane #oncologist through purposeful science – excited to

Strong UM Fellow representation at the annual MSHO conference!

👉👉👉Thanks 🙏 🙏 🙏 to Michigan Medicine Div HemOnc for hosting me for Grand Rounds visiting Professor talk and visit ! Nate Wilson Kamran Mirza MD PhD - کامران مرزا Shematologist, MD Kristen Pettit Bernie Marini 🙌 #BPDCN #MPNSM #RareDisease #leusm

Hot off the press. Excited to share work done by stellar Society of Urologic Oncology fellow Amanda Myers mentored by Ashish M. Kamat, MD, MBBS Further advancing knowledge on aggressive #bladdercancer subtypes. T1 nonmuscle invasive small cell neuroendocrine carcinoma 🔗 sciencedirect.com/science/articl…

END OF YEAR TOP ALL CANCER TRIALS in 2024! JUST in on 1 JAN 2025: Paper 1: #neoadjuvant checkpoint inhibitor Phase 3 trial in melanoma! #NADINA trial shows ipi+nivo significantly improves EFS vs. adjuvant nivo alone (HR 0.32, p<0.0001). #ASCO24 plenary #Melanoma ASCO

🔥 OUR LATEST #OriginalResearch in CancerMedicine on Small Cell Neuroendocrine Carcinoma of the Urinary Tract (SCNEC-URO)👉What drives post-surgical relapse in this aggressive disease? Omar Alhalabi, MD Matt Campbell MD, MS MD Anderson Cancer Center 🔗bit.ly/3E3R7lJ A thread🧵1/

Congrats Nate Wilson on this well written piece! Neoadjuvant treatment in advanced resectable melanoma and the need for a predictive biomarker - is pathologic complete response (pCR) the answer? - The American Journal of Surgery americanjournalofsurgery.com/article/S0002-… UM Hematology/Oncology Fellowship

⚡️NOW in Journal for ImmunoTherapy of Cancer👉Nivo/ipi in metastatic variant histology renal cell carcinoma 👇Mentored by kidney cancer legend #NizarTannirMD & Omar Alhalabi, MD, happy to share our experience MD Anderson Cancer Center co-led w/ terrific friends Nate Wilson & Jaanki! 🔗bit.ly/3QFrzON🧵1/

BRIDGING GU ONCOLOGY & INTERNAL MEDICINE - Omar Alhalabi, MD #NupurKikaniMD MD Anderson Cancer Center Led with star colleague Nate Wilson (Ex-Chief UTHealth Houston IM Residency), we share an ORIGINAL report on mgt of systemic toxicity of an ADC that changed bladder cancer care 🔗shorturl.at/7Nrhz👇1/

🚨Hot off the press: A simultaneous publication in JCO Oncology Practice alongside Vivek Patel, MD’s presentation highlighting the 1st cluster randomized study evaluating podcasts for heme/onc education! The outcome: The Fellow On Call and TwoOncDocs should be included for h/o fellow education!

Always a great time at UM ASCO reception!

I’ve been bad at keeping up with posting during fellowship, but excited to announce that I will be starting my post-training career as a melanoma medical oncologist Winship Cancer Institute of Emory University next week. So grateful for my mentors, support system, and very excited for this next chapter!